The value of open-source clinical science in pandemic response: lessons from ISARIC.

ISARIC Clinical Characterisation Group

Open source

DOI
10.1016/s1473-3099(21)00565-x
Published
2021 Dec
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-21-00565-x,
  title = {The value of open-source clinical science in pandemic response: lessons from ISARIC.},
  author = {ISARIC Clinical Characterisation Group},
  year = {2021},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(21)00565-x},
  url = {https://doi.org/10.1016/s1473-3099(21)00565-x}
}

RIS

TY  - JOUR
TI  - The value of open-source clinical science in pandemic response: lessons from ISARIC.
AU  - ISARIC Clinical Characterisation Group
PY  - 2021
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(21)00565-x
UR  - https://doi.org/10.1016/s1473-3099(21)00565-x
ER  - 

APA

Group, I. C. C. (2021). The value of open-source clinical science in pandemic response: lessons from ISARIC.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(21)00565-x

Source records